Centerpoint Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Buy
+532
New +$212K 0.14% 104
2025
Q2
– Sell
-1,153
Closed -$359K – 101
2025
Q1
$359K Hold
1,153
– – 0.35% 65
2024
Q4
$301K Buy
+1,153
New +$342K 0.29% 68

Other funds holding AMGN

Centerpoint Advisory Group's AMGN Position: Q3 2026 in Review

Centerpoint Advisory Group opened a new position in Amgen (AMGN) in Q3 2026: 532 shares worth $224K. The stake represents 0.14% of the portfolio and ranks #104 among its holdings. This is a return to the name: Centerpoint Advisory Group previously reported a position in AMGN as recently as Q1 2025.

Centerpoint Advisory Group first reported a position in AMGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $359K in Q1 2025. 3,270 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Centerpoint Advisory Group held 532 shares of Amgen worth $224K as of Q3 2026.
  • Amgen was a new Centerpoint Advisory Group position in Q3 2026.
  • Amgen made up 0.14% of Centerpoint Advisory Group's portfolio in Q3 2026, its #104 holding.
  • Centerpoint Advisory Group first reported a position in Amgen in Q4 2024 and has held it in 3 quarters since.
  • Centerpoint Advisory Group's Amgen position peaked at $359K in Q1 2025.
  • 3,270 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Centerpoint Advisory Group's 13F filing for Q3 2026, filed 23 Oct 2026.